This ACE Clinical Guidance (ACG) highlights the importance of early identification of patients at increased risk of chronic kidney disease (CKD), providing evidence-based recommendations for timely detection, diagnosis, and staging of CKD.
Download the PDF below to access the ACG.
CKD – early detection (October 2022)
CKD – early detection References (Oct 2022)
|1.||Identify patients at increased risk of CKD by assessing their risk factors and determine the need to evaluate for CKD. |
|2.||Diagnose CKD if any of the following is present for at least three months:|
- GFR < 60 mL/min/1.73m2
- UACR ≥ 3 mg/mmol (≥ 30 mg/g)
- Other marker of kidney damage
|3.||Determine the stage of CKD based on GFR, UACR, and the cause(s) of CKD.|
|4.||For patients diagnosed with CKD, discuss the diagnosis and management options with the patient.|
|5.||For patients who do not have CKD but are at increased risk, monitor for CKD regularly.|
|6.||Referral to a specialist could be made at any point.|
Click here to give us feedback on this ACG.